During the past decade, Higashi Cardiovascular clinic conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Higashi Cardiovascular clinic" are "Ischemic Heart Disease" (1 trials), "Long Coronary Artery Disease" (1 trials), "Restenosis" (1 trials), "Stable Angina Pectoris" (1 trials) and "Unstable Angina Pectoris" (1 trials). Many other conditions were trialed in "Higashi Cardiovascular clinic" in a lesser frequency.

Most popular intervention types in "Higashi Cardiovascular clinic" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Intracoronary stent implantation" (1 trials), "Paclitaxel-eluting stent (TAXUS)" (1 trials), "Sirolimus-eluting coronary stent (Cypher)" (1 trials) and "TAXUS Liberté paclitaxel-eluting coronary stent system" (1 trials). Other intervention names were less common.

The vast majority of trials in "Higashi Cardiovascular clinic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Higashi Cardiovascular clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Higashi Cardiovascular clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Higashi Cardiovascular clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".